H1 2026 U.S. Private Equity M&A Activity Review

The first half of 2026 marked a decisive inflection point for U.S. private equity, characterized by extreme selectivity in deployment coupled with consolidation of fundraising power among top-tier managers. According to PwC's midyear review, transaction volume contracted 67% relative to H1 2025—a sharp decline that masks a more nuanced story: deals that closed were substantially larger and more strategically targeted. Aggregate deal value actually increased nearly 10% despite the volume drop, indicating that PE sponsors abandoned broad-market deployment in favor of concentrated firepower on high-conviction opportunities. This represents a fundamental recalibration of sponsor behavior as valuations remain contested and conviction thresholds have risen.

The fundraising environment reflects similar structural dynamics. Aggregate capital raised climbed 9% in H1 2026 compared to H1 2025, yet the number of funds that closed declined, revealing significant LP reallocation toward established managers demonstrating robust realized returns. Firms with strong distributions to paid-in capital (DPI) raised capital more rapidly, while those with extended unreturned capital bases faced skepticism from LP committees, compressed fundraising targets, and prolonged processes. This bifurcation underscores a shift in how limited partners allocate: after years of compounding unreturned capital, LPs are disciplining their exposure and concentrating commitments among proven performers.

The exit market remains a persistent headwind. IPO windows have not materially widened, strategic buyer appetite remains selective, and sponsor-to-sponsor transactions continue to face valuation scrutiny. In response, continuation vehicles and GP-led secondaries have emerged as the dominant liquidity mechanism—functional alternatives that allow sponsors to extend holding periods and reset return expectations without full realization. However, these structures increasingly draw LP pushback regarding conflicts of interest, as managers deploy capital into their own funds while managing legacy holdings.

Portfolio performance diverges sharply by sector. Healthcare has proven most resilient for PE capital deployment, with take-private transactions and platform roll-ups proceeding at sustained pace. Technology, historically PE's highest-returning sector, now confronts a more complex environment as artificial intelligence reshapes the competitive and valuation dynamics of legacy software holdings. While AI creates new value creation levers for forward-thinking sponsors, it simultaneously complicates exit timing and valuation for holdings built on pre-AI business models. This heterogeneous sectoral backdrop underscores the premium sponsors are placing on sector selectivity and operational insight in the current environment.